REQUEST A DEMO
Total
USD $0.00
Search more companies

Daewoong Pharmaceutical (Thailand) Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Daewoong Pharmaceutical (Thailand) Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Daewoong Pharmaceutical (Thailand) Company Limited is based in Thailand, with the head office in Bangkok , Special Governed District of. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on July 24, 2026. The total number of employees is currently 5 (2024). In its most recent financial highlights, the company reported a net sales revenue increase of 8.78% in 2025. Its’ total assets recorded a growth of 56.56%. The net profit margin of Daewoong Pharmaceutical (Thailand) Company Limited increased by 3.11% in 2025.

Headquarters
1550 New Phetchaburi Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10400

Contact Details: Purchase the Daewoong Pharmaceutical (Thailand) Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Daewoong Pharmaceutical (Thailand) Company Limited report to view the information.
Financial Auditors:
Purchase the Daewoong Pharmaceutical (Thailand) Company Limited report to view the information.
Incorporation Date:
July 24, 2026
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Daewoong Pharmaceutical (Thailand) Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
8.78%
Total Operating Revenue
9.47%
Operating Profit
179.25%
Net Profit/Loss for the Period
182.74%
Total Assets
56.56%
Total Equity
71.41%
Operating Profit Margin
3.85%
Net Profit Margin
3.11%
Return on Equity (ROE)
-224.54%
Quick Ratio
0.24%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?